GS vs PROF · P/E 20, $324.25B cap vs rev $10.7M
Goldman Sachs Group Inc (GS) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
GS does not have a complete income-statement cache yet.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. PROF currently screens at market cap $238.7M.
Not investment advice. Open the GS and PROF stock pages for the full models.
Not investment advice.